Gentiva Health Services, Inc. (GTIV) has been upgraded today by the research analysts at investment firm FBR Capital which upgraded GTIV from a “under perform” rating to “market perform.” FBR also increased their price target for GTIV from $23 to $25 dollars. GTIV is down during intraday trading.
Gentiva is slated to release their next earnings report on July 28th, 2011 and is estimated to post EPS of 67 cents. Their last earnings report was released on May 5th, 2011 and announced EPS of 51 cents with revenue totaling 458.8 million which was up 54.4 % year to year. GTIV is currently trading below its 50 & 200-day moving averages and 2011 is a down year for the company.
Gentiva Health Services, Inc. provides home health services and hospice care throughout most of the United States. Gentiva’s continuing operations involve servicing its patients and customers through its Home Health segment and its Hospice segment. The company has market capitalization of $728,000,000 and 30,477,000 shares outstanding. GTIV has a 52-week high of $30.17 with the low being $18.93.
